Medical Products Supplies Companies

Floriansbogen, 82061 Neuried
Germany
Telephone +49 89 7244090
Fax +49 89 72440910
info@frizbiochem.de
http://www.frizbiochem.de

Product Categories

Product categories

03 Diagnostic Tests
03.06 Genetic testing, molecular diagnostics
03.06.01 DNA testing

DNA testing

DNA Custom Oligonucleotides

Our products

Product category: DNA testing
DNA Custom Oligonucleotides
Highest quality multiple modified oligonucleotides are used for FRIZ Biochem’s DNA -microarrays. Research & development experience in the synthesis of multiple modified probes enables FRIZ Biochem to offer customers superior reliable technologies & services to optimise their scientific endeavours.

A wide variety of modifications can be incorporated into an oligonucleotide at the time of synthesis. When possible, this is done using a modified solid support (CPG) for 3′-modifications or a specialised phosphoramidite reagent for internal and 5′-modifications.

Certain modifications are not available as a modified-CPG or phosphoramidite and must be attached to the oligo after synthesis using NHS Ester chemistry. NHS Esters react with free primary amines and result in stable, covalent attachment. A primary amine is therefore added to the oligo during synthesis to permit reaction with the desired NHS Ester.

Catalog prices for modifications and prices for standard synthesis are found.

ad: contact information

About Us

Company details
FRIZ Biochem GmbH, founded in Oct. 2004, is a privately-held biotech company located in Neuried near Munich. The company initially focused on the development of advanced electronic biochips and gradually integrated the complete workflow of molecular diagnostics into its development efforts. FRIZ Biochem offers novel, highly innovative and broadly applicable molecular diagnostics solutions (instruments, analytical techniques, chemistries, sample preparation etc.) with special emphasis on Point-of-Care applications.

FRIZ Biochem addresses the challenge of providing a combination of simplification and improved information in a time-frame where the result affects medical intervention.

ad: company